Want to create an interactive transcript for this episode?
Podcast: iForumRx.org
Episode: Is Icosapent Ethyl a QALY-ty Investment?
Description: The landmark REDUCE-IT trial demonstrated that icosapent ethyl (IPE) 4 g daily significantly reduced cardiovascular events in high-risk patients when added to statin therapy, but is a fancy fish oil supplement really worth our coin?
Guest Authors:  Joseph Nardolillo, PharmD, BCACP and Vivian Cheng, PharmD, BCPS, BCACP
Music by Good Talk